Englander Institute for Precision Medicine
Photo credit: Shutterstock

The US Food and Drug Administration last month granted accelerated approval to a new cancer drug for adult and pediatric patients with solid tumors that have a specific genetic mutation detectable through Oncomine Comprehensive, an advanced Next Generation Sequencing (NGS) test co-developed by EIPM and the Weill Cornell Medicine Pathology department.

According to the FDA, the powerful new cancer drug ...

Photo credit: Weill Cornell Medicine

Dr. Faltas is Assistant Professor of Medicine, Cell and Developmental Biology at Weill Cornell Medicine, and Director of Bladder Cancer Research at the Englander Institute for Precision Medicine.

We hope you enjoy learning more about the work of Dr. Faltas and his team. 

Please provide a brief overview of your background and work.

My name is Bishoy Faltas. My laboratory focuses on studying bladder cancer as a model...

Photo Credit: World Science Festival / Greg Kessler

At the Englander Institute for Precision Medicine, we take our commitment to mentoring young scientists and encouraging the next generation of investigators very seriously.

So when the directors of the World Science Academy, a pre-college program for gifted New York City high school students, approached us to host more than 100 local students and teach them about our work and mission, we quickly accepted and together developed a program that would be interesting and informative. 

...